Palisade Bio, Inc. announced unaudited earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported Loss from operations were $32,858,000 against $1,841,000 a year ago. Net loss was $31,746,000 against $1,851,000 a year ago. Basic loss per share were $3.59 against $0.67 a year ago. Diluted loss per share were $4.10 against $0.67 a year ago. For the six months, the company reported Loss from operations were $34,811,000 against $4,236,000 a year ago. Net loss was $35,776,000 against $4,235,000 a year ago. Basic loss per share were $6.17 against $1.53 a year ago. Diluted loss per share were $6.96 against $1.53 a year ago.